Funder: NOVO NORDISK PHARMA, S.A.

Call: (NOVO NORDISK PHARMA, S.A.)

date_range Duration: from 01 September 2024 to 31 December 2024 (4 months) Finished
€25,000.00

Of National scope. With a Private character.

Researchers